News

Thomas M. Maddox, MD, MSc, Professor of Medicine in the Cardiovascular Division at WashU Medicine, and colleagues recently published an Expert Consensus Decision Pathway (ECDP) for the many decisions required in the management and treatment of patients with heart failure with reduced ejection fraction (HFrEF). The document was published in the Journal of the American College of Cardiology.

Dr. Angela Brown, Professor of Medicine in the Cardiovascular Division, is among this year’s awardees for the Partnership Development and Sustainability Support Program with the Washington University School of Medicine ICTS.

A new study from researchers at Washington University School of Medicine in St. Louis bolsters previous findings that polypills are beneficial in preventing heart attacks and strokes and reducing deaths among people with cardiovascular risk factors, including high blood pressure and high cholesterol. In this meta-analysis, the polypills investigated included at least one statin — a cholesterol-lowering drug — and at least one blood pressure-lowering drug.

We are pleased to invite you to the 21st Annual Meeting of the Society for Heart and Vascular Metabolism (SHVM), to be held in Saint Louis, Missouri, from Sunday, September 8th to Wednesday the 11th, 2024. In keeping with the 20-year tradition of SHVM meetings, this event will gather investigators from around the globe to provide a forum for the free exchange of ideas, to promote scientific interactions between young researchers and senior scientists in formal and informal settings, and to provide an atmosphere that fosters new collaborations.

Professor of Medicine Dr. Thomas Maddox was quoted in the article “‘Nicety’ vs. ‘necessity’: 37 impressions of AI in healthcare” in Becker’s Hospital Review.

Dr. Nishath Quader, Associate Professor of Medicine in the Cardiovascular Division, recently was among the authors of a paper highlighting the risks of radiation exposure to medical providers working on cardiovascular imaging.